Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
May
31
2023
 AAFCO Comments on the Pet Food Institute’s Proposed New Federalized Regulatory System for Pet Food Keller and Heckman LLP
May
31
2023
 South Korea Looks to Tighten Biometrics Laws Amid Generative AI Squire Patton Boggs (US) LLP
May
31
2023
 Majority of States Have Legalized Marijuana, but OSHA’s Post-Incident Drug-Testing Guidance Hasn’t Changed Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
30
2023
 FDA Studies Foreshadow Potential Changes to Direct-to-Consumer Prescription Drug Advertising Nelson Mullins
May
30
2023
 EPA Proposes Updates to TSCA New Chemicals Regulations; Comments Due July 25, 2023 Bergeson & Campbell, P.C.
May
30
2023
 Trending in Telehealth: May 16 – 22, 2023 McDermott Will & Schulte LLP
May
29
2023
 New Washington State Law Will Protect Job Applicants From Discrimination Based on Off-Duty Marijuana Use Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
28
2023
 New Consumer Product Safety Regulations In The EU Barnes & Thornburg LLP
May
26
2023
 ECHA Publishes Annual Report on Helpdesk Activities Bergeson & Campbell, P.C.
May
26
2023
 China Proposes to Amend GB 4806.1 General Safety Standard for Food-Contact Materials Keller and Heckman LLP
May
26
2023
 Analogous Art Must Be Compared to Challenged Patent McDermott Will & Schulte LLP
May
26
2023
 Mcdermottplus Check-Up: May 26, 2023 McDermott Will & Schulte LLP
May
25
2023
 Florida Bans Offshoring of Certain Patient Information Sheppard, Mullin, Richter & Hampton LLP
May
25
2023
 Supreme Court Unanimously Affirms Amgen Repatha® Antibody Patents Invalid for Lack of Enablement Mintz
May
25
2023
 Salmonella Outbreak Linked to Papa Murphy’s Cookie Dough Keller and Heckman LLP
May
25
2023
 Minnesota Legislature Passes New Recreational Marijuana Bill Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
25
2023
 EPA Will Propose Updates to New Chemicals Regulations to Improve Efficiency, Remove LVE and LoREX Exemptions for PFAS and Certain PBTs Bergeson & Campbell, P.C.
May
25
2023
 FDA Establishes Public Docket Soliciting Comments on Nitrosamine Drug Substance-Related Impurities Nelson Mullins
May
25
2023
 White House OSTP Extends Comment Period for RFI on NNI EHS Research Strategy Bergeson & Campbell, P.C.
May
24
2023
 Implementation of FASTER Act Poses Challenge for Industry Keller and Heckman LLP
May
24
2023
 Sequencing the Impact: How AI is Boosting Genomic Medicine Foley & Lardner LLP
May
24
2023
 Mississippi Department of Health Revises Medical Cannabis Regulations: Feels Like I’ve Been Here Before Bradley Arant Boult Cummings LLP
May
23
2023
 Registration Opens for NNI’s Second Webinar on U.S. Government Activities Addressing Micro- and Nanoplastic Issues Bergeson & Campbell, P.C.
May
23
2023
 Marijuana in the Manufacturing Workplace Jackson Lewis P.C.
May
23
2023
 More Federal Action in the Pharmaceutical Sector as PBM Bill Advances in the Senate Epstein Becker & Green, P.C.
May
22
2023
 Supreme Court Voids Amgen’s Patents using “Undue Experimentation” Standard
May
19
2023
 Supreme Court Delivers the Final Blow to Amgen Bradley Arant Boult Cummings LLP
May
19
2023
 FDA Issues Draft Guidance on Decentralized Clinical Trials for Drugs, Biological Products and Devices McDermott Will & Schulte LLP
Displaying 2605 - 2632 of 12601
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters